Chronic (domiciliary) non-invasive ventilation
home NIV · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Long-term home non-invasive ventilation supports patients with chronic hypercapnic respiratory failure from COPD, obesity hypoventilation, neuromuscular and chest-wall disease. It improves symptoms, gas exchange, quality of life and, in selected groups, survival and hospital admissions.
Red flags
- Rising CO2 or falling saturations despite NIV
- Bulbar weakness with aspiration risk
- Rapidly declining vital capacity in neuromuscular disease
- Acute decompensation requiring hospital NIV/ICU
Assessment
Differential diagnosis
- Obesity hypoventilation syndrome
- COPD with chronic hypercapnia
- Neuromuscular disease (e.g. motor neurone disease, muscular dystrophy)
- Chest-wall disease (kyphoscoliosis)
- Overlap syndrome (OSA + COPD)
Investigations
- Arterial blood gas showing chronic daytime hypercapnia (and compensation)
- Overnight oximetry and transcutaneous CO2 monitoring
- Spirometry / lung volumes; sniff nasal inspiratory pressure or vital capacity in neuromuscular disease
- Sleep study to assess coexistent OSA
- Echocardiogram for cor pulmonale
- Nutritional and swallow assessment in neuromuscular disease
Management
- Confirm chronic hypercapnic respiratory failure with blood gases
- Identify the underlying disease and reversible contributors
- In COPD, confirm persistent hypercapnia (PaCO2 elevated) after recovery from any acute exacerbation
- Select appropriate interface and bilevel settings aiming to lower CO2
- Titrate inspiratory and expiratory pressures to control hypoventilation and obstructive events
- In neuromuscular disease, initiate early based on symptoms, vital capacity decline or nocturnal hypoventilation
- Monitor overnight gas exchange and adjust settings
- Educate on mask use, cleaning, humidification and alarm/emergency plans
- Arrange cough-assist and secretion management in neuromuscular disease
- Review adherence, symptoms and blood gases regularly and link to palliative/advance-care planning where relevant
Drugs & doses
No specific drug; NIV is device therapy
Oxygen entrained into the circuit titrated to target saturation if needed
Optimise bronchodilators/diuretics for the underlying disease
Secretion management (e.g. nebulised saline, mucolytics) as adjunct
Disposition
Home ventilation service; regular physiology review; integrate with neurology/palliative care for progressive disease.
Complications & pitfalls
- Mask-related pressure injury
- Aspiration and secretion retention
- Aerophagia and gastric distension
- Failure requiring escalation / tracheostomy ventilation
Exam pearls
- High-intensity NIV targeting CO2 reduction improves outcomes in stable hypercapnic COPD
- Start home NIV in COPD only after persistent hypercapnia is confirmed post-exacerbation, not during the acute event
- In neuromuscular disease, initiate before severe decompensation — monitor vital capacity trends
- Pair NIV with mechanical insufflation-exsufflation for weak cough
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.